Search

A wide variety of titanium implant modifications have been developed to improve tissue- or cell-material interactions including bone bonding, implant failure, and contact osteogenesis. Osteogenesis can be stimulated by mechanobiological signals such as topography though translation of in vivo reactions to in vitro bioactivity and stem cell culture data, and vice versa, is challenging. We hypothesized that a systematic in vitro approach comparing clinically well-accepted implant surface topographical modifications could shed light on potential cell biological mechanisms provoked by submicron-, micron- or macrostructured surfaces. In this study, we investigated the response of umbilical cord derived mesenchymal stromal cells (UC-MSCs) to anodized, particle blasted, and plasma sprayed highly porous Plasmapore surfaces, which is known to promote bony ingrowth in vivo. After 21 days, UC-MSCs undergo a morphological shift from a 2D to 3D behavior on micro- or macrostructures visualized by actin-vinculin fluorescence and are able to fill the porous surfaces completely. Cell viability after 7 days was significantly decreased on the micro- and macrostructured surfaces particle blasted and Plasmapore, compared to polished controls. The analysis of osteogenic differentiation under noninduced conditions revealed a significantly elevated ALP activity on Plasmapore, indicating a beneficial effect of this macrostructured surface toward osteogenic differentiation supported by late elevated gene expression of osteopontin evaluated by qPCR. Mineralization as well as in vitro bioactivity was pronounced on anodized surfaces. Our findings point to synergistic implant modification strategies allowing early contact osteogenesis and bone ingrowth for future implant designs. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 180-191, 2018. [ABSTRACT FROM AUTHOR]

The improvement of well-established local drug delivery (LDD) systems, often providing drug release independently of their need, is a challenge of current implant technology. Systems that sense signals caused by a certain disease, judge the magnitude of the signal and act to release the right amount of drug in response are hence searched for. Specific responsive hydrogels with antibody-antigen cross-links, whose non-covalent interaction is broken in the presence of the corresponding antigen and reclosed in its absence, are a promising candidate. However, the challenging implementation of such antigen-responsive hydrogels as implant coating and their applicability for implant-associated LDD systems have not been explored so far. In this context and in order to define adequate gel properties for the envisaged application, we prepared a matrix at examples of polyacrylamide hydrogels of different gel architectures, gel contents and cross-linking degrees and investigated their impact on the permeation of the differently sized model proteins bovine serum albumin (BSA), protein A and myoglobin in a specifically designed chamber simulating an implant-associated LDD system and the mechanical stability of the polymeric network. Water uptake, as estimated by Karl Fischer titration, which was mainly influenced by gel content, seems to primarily govern drug permeability and mechanical stability. Within the investigated matrix, a medium gel content of 15.0 w% acrylamide and N,N′-methylenebisacrylamide evidenced low drug permeability, enough tensile strength and flexibility for integration of antibody-antigen cross-links, which we could successfully evidence via fluorescence microscopy. A stimulus-triggered release of BSA through such a hydrogel could be moreover demonstrated. Copyright © 2014 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]